Centrus Energy Corp. — FY2015 Form 10-K
Reporting period: Fiscal year ended December 31, 2015. The filing also reports fourth-quarter results. Comparisons with 2014 require caution: Centrus emerged from Chapter 11 on September 30, 2014 and adopted fresh start accounting, so successor and predecessor financial statements are not directly comparable. The filing presents combined 2014 figures as supplementary, non-GAAP comparisons.
Business context and financial results
Centrus supplies low-enriched uranium (LEU) to nuclear utilities and conducts advanced centrifuge technology work. It ceased enrichment production at Paducah in 2013 and relies on inventory, Russian supply and other suppliers. LEU accounted for about 85% of 2015 revenue.
| Metric | FY2015 | 2014 comparison |
|---|---|---|
| Revenue | $418.2 million | $514.1 million combined; down 19% |
| Gross profit (loss) | $68.9 million; 16.5% margin | $(41.3) million; (8.0)% margin |
| Operating loss | $(168.4) million | $(112.8) million combined |
| Net income (loss) | $(187.4) million | $297.8 million combined |
| Cash from operating activities | $8.5 million | $(110.1) million combined |
| Cash and cash equivalents | $234.0 million at year-end | $218.8 million |
| Working capital | $307.7 million | $392.0 million |
| Debt | $247.6 million PIK Toggle Notes | $240.4 million |
Revenue fell 19%, principally as SWU sales volume declined 41%; the average billed SWU price increased 3%. Uranium sales added $64.7 million versus 2014. Gross profit improved, reflecting lower direct charges and higher average SWU pricing, partly offset by lower volumes. The 2015 gross profit included an $18.5 million contract termination fee.
The 2015 net loss included a $137.2 million non-cash impairment of excess reorganization value, $13.4 million of intangible-asset amortization, and $13.2 million of workforce-reduction charges. Prior-year net income included substantial reorganization gains, which makes the net-income comparison especially non-recurring. Fourth-quarter 2015 revenue was $157.9 million, gross profit was $82.1 million and net loss was $101.8 million; the quarter included the $137.2 million impairment.
Year-end total liabilities were $986.4 million against assets of $820.7 million, producing a stockholders’ deficit of $165.7 million. Pension benefit liabilities were $172.3 million and postretirement health and life obligations were $184.3 million. Cash from operations benefited from inventory and receivables reductions, partly offset by lower SWU purchase payables. Capital expenditures were insignificant.
Material changes, outlook and risks
- Supply agreement: Centrus negotiated a Russian Supply Agreement amendment, subject to Rosatom approval, allowing up to approximately 7.7 million SWU of remaining purchases to be rescheduled into 2023–2026, in exchange for additional SWU obligations. Minimum annual purchases remain payable even if orders are not submitted. Import quotas, customer acceptance and market prices constrain resale.
- Technology and workforce: DOE ended funding for the Piketon demonstration cascade effective October 1, 2015; development work was consolidated in Oak Ridge. Centrus announced Piketon decontamination and decommissioning (D&D) and staffing reductions in February 2016. D&D, severance and other demobilization cash costs were projected at $50–$60 million, primarily in 2016. The D&D liability was $29.4 million at year-end.
- 2016 outlook: Management projected SWU and uranium revenue of $250–$275 million, total revenue of $275–$300 million, and year-end cash of $200–$250 million. It anticipated continued DOE-funded Oak Ridge work through September 30, 2016, subject to a new UT-Battelle agreement and funding.
- Order book and market: Contracted sales order book was $2.3 billion, down from $2.7 billion at year-end 2014; approximately $0.8 billion, or 35%, remained at varying risk from American Centrifuge deployment milestones. Management cited an oversupplied market and SWU prices at decade-plus lows. The 10 largest customers represented 97% of revenue, and the three largest 53%.
- Debt and liquidity: The 8% PIK Toggle Notes mature September 30, 2019, with possible extension to 2024 if specified funding conditions are met. The notes’ estimated fair value was $36.9 million versus $247.6 million carrying value. Centrus stated it expected adequate liquidity for at least 12 months, but cash needs depend on customer deliveries, Russian purchases, government funding and demobilization spending.
- Other exposures: Centrus was in discussions with the PBGC over pension-plan matters and possible ERISA-related actions; involuntary plan termination, liens or additional funding could affect liquidity. DOE claims include a $42.8 million pension and postretirement-cost claim, fully valuation-allowed, and other disputed receivables. DOE retained rights under the 2002 DOE-USEC Agreement concerning missed milestones and centrifuge technology. NYSE MKT accepted a compliance plan, with a May 17, 2017 deadline to regain listing compliance.
Investor verification priorities
- Confirm progress on 2016 revenue and cash guidance, including the timing of customer deliveries and inventory monetization.
- Verify Rosatom approval and implementation of the Russian contract amendment, and assess purchase obligations, quotas and resale economics.
- Track actual D&D and workforce-reduction spending against the $50–$60 million estimate and the $29.4 million recorded liability.
- Review the status and possible financial impact of PBGC discussions, DOE litigation and DOE receivables, and DOE agreement remedies.
- Monitor order-book retention, customer concentration, listing-plan milestones and the ability to fund pension, debt-interest and operating obligations.